Indication

Kidney transplant rejection

Kidney transplant rejection is an immunologic complication occurring in renal allograft recipients where the host immune system identifies donor human leukocyte antigens as foreign and mounts an alloimmune attack. Read more about Kidney transplant rejection

5 drugs 4 manufacturers

Advertisement

Drugs that treat it

Common Kidney transplant rejection therapies.

Showing 1–5 of 5 drugs

Filter & compare in the drug finder →Opens the drug finder with Kidney transplant rejection preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Kidney transplant rejection.

Kidney transplant rejection is an immunologic complication occurring in renal allograft recipients where the host immune system identifies donor human leukocyte antigens as foreign and mounts an alloimmune attack.

It primarily compromises the renal system and allograft vasculature, categorized temporally and mechanistically into hyperacute, acute, or chronic forms driven by T-cell-mediated pathways, donor-specific antibody-mediated injury, or mixed mechanisms.

Clinically, rejection manifests as acute or progressive graft dysfunction characterized by elevated serum creatinine, reduced urine output, proteinuria, and characteristic histopathologic features including tubulitis, interstitial inflammation, or microvascular capillaritis.

Personalize your experience

Follow Kidney transplant rejection and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it